174 related articles for article (PubMed ID: 29920525)
1. The regulatory ancestral network of surgical meshes.
Zargar N; Carr A
PLoS One; 2018; 13(6):e0197883. PubMed ID: 29920525
[TBL] [Abstract][Full Text] [Related]
2. The Complex Process of Using the Interconnected Knee Arthroplasty Device Clearance Pathway.
Zhu A; Ying X; Pean CA; Sheth NP; Cross MB; Gonzalez Della Valle A; Premkumar A
HSS J; 2022 Nov; 18(4):462-468. PubMed ID: 36258781
[No Abstract] [Full Text] [Related]
3. The Interconnected Ancestral Network of Hip Arthroplasty Device Approval.
Premkumar A; Zhu A; Ying X; Pean CA; Sheth NP; Cross MB; Gonzalez Della Valle A
J Am Acad Orthop Surg; 2021 Dec; 29(24):e1362-e1369. PubMed ID: 34161960
[TBL] [Abstract][Full Text] [Related]
4. Mapping the genealogy of medical device predicates in the United States.
Pai DB
PLoS One; 2021; 16(10):e0258153. PubMed ID: 34618861
[TBL] [Abstract][Full Text] [Related]
5. Shoulder arthroplasty device clearance: an ancestral network analysis.
Zhu A; Ying X; Carey EG; Pean CA; Premkumar A; Fu MC; Taylor SA
J Shoulder Elbow Surg; 2023 Mar; 32(3):671-676. PubMed ID: 36279987
[TBL] [Abstract][Full Text] [Related]
6. Use of Recalled Devices in New Device Authorizations Under the US Food and Drug Administration's 510(k) Pathway and Risk of Subsequent Recalls.
Kadakia KT; Dhruva SS; Caraballo C; Ross JS; Krumholz HM
JAMA; 2023 Jan; 329(2):136-143. PubMed ID: 36625810
[TBL] [Abstract][Full Text] [Related]
7. Overview of high-risk medical device recalls in obstetrics and gynecology from 2002 through 2016: implications for device safety.
Janetos TM; Ghobadi CW; Xu S; Walter JR
Am J Obstet Gynecol; 2017 Jul; 217(1):42-46.e1. PubMed ID: 28500861
[TBL] [Abstract][Full Text] [Related]
8. Lack of publicly available scientific evidence on the safety and effectiveness of implanted medical devices.
Zuckerman D; Brown P; Das A
JAMA Intern Med; 2014 Nov; 174(11):1781-7. PubMed ID: 25265047
[TBL] [Abstract][Full Text] [Related]
9. Association Between Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance.
Everhart AO; Sen S; Stern AD; Zhu Y; Karaca-Mandic P
JAMA; 2023 Jan; 329(2):144-156. PubMed ID: 36625811
[TBL] [Abstract][Full Text] [Related]
10. US Food and Drug Administration Clearance of Moderate-Risk Otolaryngologic Devices via the 510(k) Process, 1997-2016.
Rathi VK; Gadkaree SK; Ross JS; Kozin ED; Sethi RK; Naunheim MR; Puram SV; Gray ST
Otolaryngol Head Neck Surg; 2017 Oct; 157(4):608-617. PubMed ID: 28786317
[TBL] [Abstract][Full Text] [Related]
11. An overview of Food and Drug Administration regulation of drugs, biologics, and devices to be used for management of periodontal diseases.
Tylenda CA; Weintraub M
Ann Periodontol; 1997 Mar; 2(1):11-7. PubMed ID: 9151539
[TBL] [Abstract][Full Text] [Related]
12. Medical device recalls and the FDA approval process.
Zuckerman DM; Brown P; Nissen SE
Arch Intern Med; 2011 Jun; 171(11):1006-11. PubMed ID: 21321283
[TBL] [Abstract][Full Text] [Related]
13. Analysis of FDA-Approved Orthopaedic Devices and Their Recalls.
Day CS; Park DJ; Rozenshteyn FS; Owusu-Sarpong N; Gonzalez A
J Bone Joint Surg Am; 2016 Mar; 98(6):517-24. PubMed ID: 26984921
[TBL] [Abstract][Full Text] [Related]
14. Orbital Implants Receiving Food and Drug Administration Premarket Notification.
Corcoran Ruiz KM; Vaishnav YJ; Desautels J; Schaefer JL; Migliori ME; Yilmaz T
Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):503-506. PubMed ID: 35699217
[TBL] [Abstract][Full Text] [Related]
15. Substantial Equivalence Premarket Review: the Right Approach for Most Medical Devices.
Shapiro JK
Food Drug Law J; 2014; 69(3):365-97, i. PubMed ID: 27382855
[TBL] [Abstract][Full Text] [Related]
16. FDA-cleared artificial intelligence and machine learning-based medical devices and their 510(k) predicate networks.
Muehlematter UJ; Bluethgen C; Vokinger KN
Lancet Digit Health; 2023 Sep; 5(9):e618-e626. PubMed ID: 37625896
[TBL] [Abstract][Full Text] [Related]
17. Performing clinical studies involving hernia mesh devices: what every investigator should know about the FDA investigational device exemption (IDE) process.
Ashar BS; Dang JM; Krause D; Luke MC
Hernia; 2011 Dec; 15(6):603-5. PubMed ID: 21909977
[TBL] [Abstract][Full Text] [Related]
18. Assessment of cardiovascular and noncardiovascular medical device recalls.
Somberg JC; McEwen P; Molnar J
Am J Cardiol; 2014 Jun; 113(11):1899-903. PubMed ID: 24837271
[TBL] [Abstract][Full Text] [Related]
19. Medical devices: US medical device regulation.
Jarow JP; Baxley JH
Urol Oncol; 2015 Mar; 33(3):128-32. PubMed ID: 25458071
[TBL] [Abstract][Full Text] [Related]
20. Incremental Revisions across the Life Span of Ophthalmic Devices after Initial Food and Drug Administration Premarket Approval, 1979-2015.
Gopal AD; Rathi VK; Teng CC; Del Priore L; Ross JS
Ophthalmology; 2017 Aug; 124(8):1237-1246. PubMed ID: 28501378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]